Snowball logo
logo
COYA

Coya Therapeutics Inc. Common Stock

COYA β€’ NASDAQ
$4.96+$0.09Β  (1.85%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
--6.0022063.5540617.9457538.019145
COGS
0.01614.4124985.50152711.870.0274-
Gross Profit
(0.0161)(4.412498)0.500679(8.311593)7.9183928.012305
Operating Expenses & Income
Operating Income
(4.87031)(9.811939)(7.903349)(17.25)(20.27)(22.63)
Total Operating Expenses
4.870315.3994418.4040288.93811828.1830.65
R&D Expenses
2.5421354.9374986.04471311.8916.7318.77
Selling General & Admin Expenses
2.3120424.847087.8334818.88575711.4511.86
Earnings from Continuing Operations
Interest Expense
(0.0215)(2.433)----
Interest Income
------
Income Tax Expense
(0.0215)2.4330.723852(0.720287)0.0030890.003089
Net Income
Net Income
(4.891792)(12.24)(7.987836)(14.88)(21.23)(21.67)
Supplemental
EBIT
(4.891792)(9.286939)(7.360163)(17.22)(21.22)(22.09)
EBITDA
(4.875659)(9.259578)(7.332802)(17.2)(21.2)(22.07)
In millions of USD, except % and values per 1 share